RecruitingNot ApplicableNCT04949464

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study


Sponsor

AIDS Malignancy Consortium

Enrollment

100 participants

Start Date

Mar 22, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial evaluates the usefulness of using a smartphone-based HIV-specific smoking cessation intervention at the time of lung cancer screening in helping people living with HIV quit smoking. Positively Smoke Free - Mobile may help patients with HIV quit smoking.


Eligibility

Min Age: 45 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This feasibility study is testing whether a combination of lung cancer screening (using low-dose CT scans) and smoking cessation support through a smartphone app can help people living with HIV (who face a higher lung cancer risk) to quit smoking. The study is exploring whether this approach is practical and acceptable in this population. **You may be eligible if...** - You are living with HIV and between 45 and 80 years old - You are currently a smoker (confirmed by a breath test) - You have a significant smoking history (20+ pack-years) and meet criteria for lung cancer screening - You are on HIV treatment with a CD4 count of at least 200 cells/uL - You own a smartphone compatible with the study app - You can read at a basic level (assessed by a short literacy test) **You may NOT be eligible if...** - You are currently using or recently used (within 30 days) other smoking cessation treatments - You have had lung cancer before - You are pregnant or breastfeeding - You have had a serious lung infection in the past 3 months - You have had a chest CT scan in the past 12 months - You have an uncontrolled serious illness or condition that limits your life expectancy or ability to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREComputed Tomography

Undergo LDCT

BEHAVIORALSmoking Cessation Intervention

Use Positively Smoke Free - Mobile


Locations(11)

UC San Diego Moores Cancer Center

La Jolla, California, United States

George Washington University

Washington D.C., District of Columbia, United States

Moffitt Cancer Center

Tampa, Florida, United States

Washington University School of Medicine

St Louis, Missouri, United States

Weill Cornell Medicine - Cornell Clinical Trials Unit

New York, New York, United States

Mount Sinai Hospital

New York, New York, United States

Montefiore Medical Center

The Bronx, New York, United States

The Ohio State University James Cancer Hospital

Columbus, Ohio, United States

Thomas Jefferson University

Philadelphia, Pennsylvania, United States

University of Texas M.D. Anderson Cancer Center

Houston, Texas, United States

Virginia Mason Medical Center

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04949464


Related Trials